DEA requirements for EPCS demystified

August 3, 2015

According to the Centers for Disease Control and Prevention (CDC) there are nearly 23,000 deaths caused by overdoses of prescription medications every year. That's more than the number of deaths from cocaine and heroin combined. States have responded with new legislation, including New York’s I-STOP requirements, which mandate the electronic transmission of all prescriptions, including prescriptions for controlled substances, by March 27, 2016.

To help providers navigate the complex legal requirements of e-prescribing, Imprivata is running a series of “EPCS – Ask the Experts” webinars. In the most recent webinar, Bill Winsley, former Executive Director of the Ohio State Board of Pharmacy, Imprivata CTO, David Ting, and Imprivata Director of Nursing & Clinical Workflow, Chris McKay, answer FAQs relating to Electronic Prescribing of Controlled Substances (EPCS).

Some of the questions they cover include:

DEA and New York State I-STOP requirements for e-prescribing
EPCS workflows
Two-factor authentication
Pharmacy readiness

Learn how to get ready for EPCS, by viewing the on-demand webinar, reading the webinar transcript, or exploring FAQs on the Imprivata website at Imprivata.com/EPCS.